China-based Frontier Biotechnologies Inc. (SHA: 688221) has announced a collaboration agreement with the Chinese Association of STD and AIDS Prevention and Control (CASAPC) to facilitate precision prevention and control of AIDS in China. The partnership aims to enhance the effectiveness of existing measures and better allocate resources for combating the disease. Financial details of the agreement were not disclosed.
Collaboration Objectives
The collaboration is designed to bolster the precision and effectiveness of China’s AIDS prevention and control measures. It will focus on leveraging big data to innovate and improve the efficiency of prevention and control efforts. Additionally, the partnership aims to construct an independent AIDS real-world data (RWD) bank, which will serve as a valuable resource for ongoing research and policy development.-Fineline Info & Tech
